Enliven Therapeutics ELVN Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Enliven Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enliven Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enliven Therapeutics's net income?
- Enliven Therapeutics (ELVN) reported net income of -$23.63M in Q1 2026.
- How has Enliven Therapeutics's net income changed year-over-year?
- Enliven Therapeutics's net income increased by 17.2% year-over-year, from -$28.54M to -$23.63M.
- What is the long-term trend for Enliven Therapeutics's net income?
- Over 4 years (2021 to 2025), Enliven Therapeutics's net income has grown at a 19.2% compound annual growth rate (CAGR), from -$51.38M to -$103.69M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.